poisar

Stocks · News reference

Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate

Benzinga Newsdesk

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

FMS
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Na

    Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

    Fresenius Medical Care is scaling up its 5008X CAREsystem rollout, converting 227 U.S. clinics to the new technology by July 2026, representing 10% of its machine base. The company has performed over 600,000 treatments including 100,000+ high-volume hemodiafiltration treatments, showing clinical promise with 40% fewer muscle cramps. However, near-term headwinds include weak U.S. treatment volume growth (-0.9%), TDAPA reimbursement pressure (€50 million drag expected), and significant rollout implementation costs.

    FMSDVAOM